What is it used for?
FOTIVDA is indicated for the treatment of adult patients with relapsed or refractory advanced renal cell carcinoma (RCC) following two or more prior systemic therapies.FOTIVDA is indicated for the treatment of adult patients with relapsed or refractory advanced renal cell carcinoma (RCC) following two or more prior systemic therapies.
Read the primary sourceThis source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.
Product details
- Active ingredient
- tivozanibtivozanib
- Form and strength
- CAPSULE · 0.89 mg; CAPSULE · 1.34 mgCAPSULE · 0.89 mg; CAPSULE · 1.34 mg
- Manufacturer / applicant
- AVEO PHARMACEUTICALS, INC.AVEO PHARMACEUTICALS, INC.
Capsules: 1.34 mg: bright yellow opaque cap imprinted with "TIVZ" in dark blue ink and a bright yellow opaque body imprinted with "SD" in dark blue ink. 0.89 mg: dark blue opaque cap imprinted with "TIVZ" in yellow …Capsules: 1.34 mg: bright yellow opaque cap imprinted with "TIVZ" in dark blue ink and a bright yellow opaque body imprinted with "SD" in dark blue ink. 0.89 mg: dark blue opaque cap imprinted with "TIVZ" in yellow …
Safety and clinical review
- Hypertension and Hypertensive CrisisHypertension and Hypertensive Crisis
- Cardiac FailureCardiac Failure
- Cardiac Ischemia and Arterial Thromboembolic EventsCardiac Ischemia and Arterial Thromboembolic Events
- Venous Thromboembolic EventsVenous Thromboembolic Events
- Hemorrhagic EventsHemorrhagic Events
- ProteinuriaProteinuria
Ask your clinician to review the complete label, medical history, other medicines, allergies, pregnancy or breastfeeding and any required monitoring. Do not start, stop or change treatment from this page.
Read the primary sourcePrepare your enquiry
Include the brand or generic name, strength, dosage form, requested quantity and country where care is needed. You can attach a prescription when you continue.
Questions patients ask
What is FOTIVDA used for?
FOTIVDA is indicated for the treatment of adult patients with relapsed or refractory advanced renal cell carcinoma (RCC) following two or more prior systemic therapies.FOTIVDA is indicated for the treatment of adult patients with relapsed or refractory advanced renal cell carcinoma (RCC) following two or more prior systemic therapies.
This source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.
Which formulation of FOTIVDA should I ask about?
CAPSULE · 0.89 mg; CAPSULE · 1.34 mgCAPSULE · 0.89 mg; CAPSULE · 1.34 mg
Read the primary sourceWhat determines the price of FOTIVDA?
A current quote depends on the exact presentation, quantity, provider and access arrangements. A catalogue entry is not a stock or delivery promise. Medical charges are paid to the provider, separately from coordination fees.
What should I check before using FOTIVDA?
Ask your clinician to review the complete label, medical history, other medicines, allergies, pregnancy or breastfeeding and any required monitoring. Do not start, stop or change treatment from this page.
Sources and review scope
FDA prescribing informationThis source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.